Seeing Is Believing
Healthcare - Sector
RARE is currently covered by 19 analysts with an average price target of $44.31. This is a potential upside of $27.63 (189.61%) from yesterday's end of day stock price of $15.3.
Ultragenyx's activity chart (see below) currently has 332 price targets and 282 ratings on display. The stock rating distribution of RARE is 90.2% BUY and 9.8% HOLD.
Analysts average stock forecasts to be materialized ratio is 43.65% with an average time for these price targets to be met of 160.98 days.
Highest price target for RARE is $96, Lowest price target is $16, average price target is $44.31.
Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS. First documented stock forecast 24-Feb-2014.
Currently out of the existing stock ratings of RARE, 46 are a BUY (90.2%), 5 are a HOLD (9.8%).
9/3/03 3 for 2
9/6/00 3 for 2
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Sep-2026
$19
$3.7 (24.18%)
$25
Buy Since 02-Nov-2021
$28
$12.7 (83.01%)
$58
Buy Since 29-Dec-2025
$18
$2.7 (17.65%)
$46
Buy Since 27-Jul-2025
$25
$9.7 (63.40%)
$50
Hold Since 28-Jan-2021
$23
$7.7 (50.33%)
$26
What is RARE (Ultragenyx) average time for price targets to be met?
Which analyst most recently updated their price target on RARE (Ultragenyx)?
Which analyst has the most public recommendations on RARE (Ultragenyx)?
Which analyst is the currently most bullish on RARE (Ultragenyx)?
Which analyst is the currently most reserved on RARE (Ultragenyx)?